CorMedix (CRMD) Gains from Sales and Divestitures (2023 - 2025)
CorMedix's (CRMD) quarterly Gains from Sales and Divestitures came in at $371166.0 in Q4 2025, up 154.97% year-on-year from $145574.0 in Q4 2024, and up 154.97% quarter-over-quarter from $145574.0 in Q4 2024.
CorMedix (CRMD) Gains from Sales and Divestitures (2023 - 2025) Analysis & Trends
CorMedix has disclosed Gains from Sales and Divestitures across 3 years of filings, most recently posting $371166.0 for Q4 2025.
- Gains from Sales and Divestitures for Q4 2025 came in at $371166.0, up 154.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $371166.0 (up 154.97% YoY), and the FY2025 annual result was $371166.0, up 154.97% from the prior year.
- Gains from Sales and Divestitures came in at $371166.0 for Q4 2025 at CorMedix, up from $145574.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $371166.0 in Q4 2025 to a low of $42844.0 in Q2 2024.
- The 3-year median for Gains from Sales and Divestitures is $103734.0 (2023), against an average of $141232.4.
- Across the five-year window, Gains from Sales and Divestitures soared 40.33% in 2024 and jumped 154.97% in 2025, its largest moves.
- CorMedix's Gains from Sales and Divestitures stood at $103734.0 in 2023, then jumped by 40.33% to $145574.0 in 2024, then surged by 154.97% to $371166.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $371166.0 (Q4 2025), $145574.0 (Q4 2024), and $42844.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 371,166.00 |
| Dec 31, 2025 | 371,166.00 |
| Dec 31, 2024 | 145,574.00 |
| Dec 31, 2024 | 145,574.00 |
| Sep 30, 2024 | 42,844.00 |
| Sep 30, 2024 | 42,844.00 |
| Jun 30, 2024 | 42,844.00 |
| Jun 30, 2024 | 42,844.00 |
| Dec 31, 2023 | 103,734.00 |
| Dec 31, 2023 | 103,734.00 |